Skip to main content
Premium Trial:

Request an Annual Quote

Santaris Inks Drug-discovery Deal with Bristol-Myers Squibb

Premium

Santaris Pharma this week announced that it has formed a world-wide drug discovery alliance with Bristol-Myers Squibb.

Under the terms of the deal, the companies will discover and develop drugs against undisclosed targets using Santaris’ locked nucleic acid technology.

Santaris will receive a $10 million upfront payment, and stands to receive an additional $90 million in milestones and funding. Santaris is also eligible for royalties on the sale of products resulting from the arrangement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.